99585-14-5

Basic information

• Product Name: 2-Chloro-6-methyl-benzoic acid methyl ester
• Synonyms: 2-Chloro-6-methyl-benzoic acid methyl ester
• CAS NO: 99585-14-5
• Molecular Formula: C₉H₉ClO₂
• Molecular Weight: 184.61956
• Mol File: 99585-14-5.mol
• Article Data: 8

Chemical Properties

• Appearance: /
• Storage Temp.: Sealed in dry,Room Temperature
• CAS DataBase Reference: 2-Chloro-6-methyl-benzoic acid methyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: 2-Chloro-6-methyl-benzoic acid methyl ester(99585-14-5)
• EPA Substance Registry System: 2-Chloro-6-methyl-benzoic acid methyl ester(99585-14-5)

Safety Data

• Hazardous Substances Data: 99585-14-5(Hazardous Substances Data)

Usage

General Description

2-Chloro-6-methyl-benzoic acid methyl ester, also known as 2-Chloro-6-methylbenzoic acid methyl ester, is a chemical compound with the molecular formula C9H9ClO2. It is a white crystalline powder that is commonly used in the pharmaceutical industry as an intermediate for the synthesis of various organic compounds. It is also used as a building block in the production of pesticides, dyes, and other chemical products. This chemical has a wide range of applications and is known for its stability and low toxicity, making it a valuable component in many industrial processes.

Upstream product

• 21327-86-6 2-chloro-6-methylbenzoic acid 
• 74-88-4 methyl iodide 
• 67-56-1 methanol 
• 89894-44-0 2-chloro-6-methylbenzoyl chloride 
• 77-78-1 dimethyl sulfate 
• 201230-82-2 carbon monoxide 
• 5100-98-1 1-chloro-2-iodo-3-methylbenzene 
• 85070-46-8 2-chloro-6-methylbenzenediazonium tetrafluoroborate 

Downstream Products

• 21327-86-6 2-chloro-6-methylbenzoic acid 
• 482578-63-2 methyl 2-(bromomethyl)-6-chlorobenzoate 
• 89894-44-0 2-chloro-6-methylbenzoyl chloride 
• 116621-21-7 methyl 2-chloro-4-hydroxy-6-methylbenzoate 

Relevant articles and documents

Isosteric analogs of lenalidomide and pomalidomide: Synthesis and biological activity

A series of analogs of the immunomodulary drugs lenalidomide (1) and pomalidomide (2), in which the amino group is replaced with various isosteres, was prepared and assayed for immunomodulatory activity and activity against cancer cell lines. The 4-methyl and 4-chloro analogs 4 and 15, respectively, displayed potent inhibition of tumor necrosis factor-α (TNF-α) in LPS-stimulated hPBMC, potent stimulation of IL-2 in a human T cell co-stimulation assay, and anti-proliferative activity against the Namalwa lymphoma cell line. Both of these analogs displayed oral bioavailability in rat.

Novel compounds useful for bradykinin B1 receptor antagonism

Disclosed are compounds that are bradykinin B1 receptor antagonists and are useful for treating diseases, or relieving adverse symptoms associated with disease conditions, in mammals mediated by bradykinin B1 receptor.

ISOQUINOLINONE DERIVATIVES AND THEIR USE AS THERAPEUTIC AGENTS

This invention is directed to isoquinolinone derivatives and their use in modulating the activity of orphan nuclear receptors, pharmaceutical compositions containing such derivatives, and methods of using such derivatives in treating disease-states associ